Quadrisol
vedaprofen
Table of contents
Overview
This is a summary of the European public assessment report (EPAR) for Quadrisol. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Quadrisol.
For practical information about using Quadrisol, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Authorisation details
Product details | |
---|---|
Name |
Quadrisol
|
Agency product number |
EMEA/V/C/000032
|
Active substance |
vedaprofen
|
International non-proprietary name (INN) or common name |
vedaprofen
|
Species |
Horses
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QM01AE90
|
Publication details | |
---|---|
Marketing-authorisation holder |
VETCOOL B.V.
|
Revision |
18
|
Date of issue of marketing authorisation valid throughout the European Union |
04/12/1997
|
Contact address |
Otto Hahnweg 24
3542 AX Utrecht Netherlands |
Product information
25/04/2017 Quadrisol - EMEA/V/C/000032 - T/0037
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Therapeutic indication
Reduction of inflammation and relief of pain associated with musculoskeletal disorders and soft-tissue lesions (traumatic injuries and surgical trauma). In cases of anticipated surgical trauma, Quadrisol can be given prophylactically at least three hours prior to elective surgery.